No Oral Modification Clause Example from Business Contracts

Separation Agreement and Release by and between James A. Reinstein and Cutera, Inc. dated as of January 4, 2019 (Filed With SEC on January 9, 2019)

Separation and Release Agreementby and between Cutera, Inc. and Jason Richey (Filed With SEC on May 12, 2021)

Separation and Release Agreement between the Registrant and Kenneth M. Bahrt, M.D., dated April 23, 2019 (Filed With SEC on April 26, 2019)

Separation Agreement and Release by and between the Registrant and Stephen J. McAndrew, Ph.D., effective as of November 26, 2018 (Filed With SEC on December 18, 2018)

Separation Agreement and Release by and between Oncobiologics, Inc. and Pankaj Mohan, Ph.D., dated July 2, 2018 (Filed With SEC on August 14, 2018)

Resignation Agreement and Release by and between X4 Pharmaceuticals, Inc. and E. Lynne Kelley, M.D., dated March 18, 2020 (Filed With SEC on March 20, 2020)

Separation Agreement, dated May 22, 2020 (Filed With SEC on July 20, 2020)

Separation Agreement, dated May 22, 2020 (Filed With SEC on May 27, 2020)

Separation Agreement and Release entered into by and between the Registrant and Elaine Sun, dated December 17, 2019 (Filed With SEC on May 22, 2020)

Separation Agreement and Release with Jianli Deng, dated August 29, 2020 (Filed With SEC on September 1, 2020)

Separation Agreement and Release with Lijun Yu, dated August 29, 2020 (Filed With SEC on September 1, 2020)

Separation Agreement and Release with Linqing Ye, dated August 29, 2020 (Filed With SEC on September 1, 2020)

Separation Agreement and Release between the Registrant and Omri Dahan dated March 17, 2021 (Filed With SEC on May 14, 2021)

Offer Letter, dated as of April 16, 2019, by and between the Registrant and Sekar Kathiresan, M.D (Filed With SEC on May 28, 2021)

Separation Agreement and Release by and between the Company and Michael Coyle dated June 29, 2021 (Filed With SEC on July 6, 2021)

Transition Agreement and Release between the Registrant and David Hilbert, Ph.D., dated January 7, 2022 (Filed With SEC on January 14, 2022)

Separation Agreement, dated as of October 8, 2021, by and between the Registrant and Zelanna Goldberg (Filed With SEC on March 17, 2022)

Transition Agreement and Release dated March 22, 2022 between the Company and Mark Kowalski (Filed With SEC on March 23, 2022)

Transition Agreement and Release by and between Registrant and Thomas E. Hale, dated February 27, 2022 (Filed With SEC on May 5, 2022)

Separation Agreement and Release, dated June 2, 2022, by and between Aravive, Inc. and Vinay Shah (Filed With SEC on June 3, 2022)

Separation Agreement and Release, dated as of June 20, 2022, by and between Blaine Davis and the Company (Filed With SEC on June 21, 2022)

Separation Agreement and Release, by and between Registrant and Marty Hahnfeld, dated May 9, 2022 (Filed With SEC on August 11, 2022)

Separation Agreement, dated December 20, 2022, between the Company and Mr. Lynch (Filed With SEC on December 23, 2022)

Separation and Release Agreement, dated December 27, 2022, by and between the Company and David Clapper (Filed With SEC on December 28, 2022)

Separation Agreement and Release by and between MedAvail Holdings, Inc. and Matt Broome (Filed With SEC on February 10, 2023)

Separation Agreement and Release, dated July 16, 2018, by and between David T. Mitchell and the registrant (Filed With SEC on August 22, 2018)

Separation Agreement and Release, dated as of August 1, 2018, between the Company and Matt Ferguson (Filed With SEC on August 13, 2018)

Transition Agreement and Release, with an effective date of January 24, 2018, by and between Lionel Bonnot and Quantenna Communications, Inc (Filed With SEC on May 1, 2018)

Separation and Release Agreement, dated April 30, 2018, between Nemus Bioscience, Inc. and Elizabeth Berecz (Filed With SEC on May 4, 2018)

TRANSITION AND SEPARATION AGREEMENT AND RELEASE (Filed With SEC on August 3, 2016)

TRANSITION, SEPARATION AND GENERAL RELEASE AGREEMENT (Filed With SEC on December 28, 2016)

Separation and Release Agreement, effective November 20, 2013, between Active Power, Inc. and Steven R. Fife (Filed With SEC on March 4, 2014)

Separation and Release Agreement, effective January 4, 2014, between Active Power, Inc. and J. Noel Foley (Filed With SEC on March 4, 2014)

Separation Agreement and Release, dated January 4, 2014, between Active Power and J. Noel Foley (Filed With SEC on May 1, 2014)

Separation Agreement and Release, dated November 7, 2013, between Active Power and Martin T. Olsen (Filed With SEC on November 18, 2013)

SEPARATION AGREEMENT AND RELEASE (Filed With SEC on March 5, 2014)

SEPARATION AGREEMENT AND RELEASE (Filed With SEC on May 15, 2015)

PHARMACYCLICS, INC. CHANGE IN CONTROL AND SEVERANCE PLAN AND SUMMARY PLAN DESCRIPTION Effective as of March 4, 2015 (Filed With SEC on March 6, 2015)

TRANSITION AGREEMENT (Filed With SEC on April 23, 2015)

VIVUS, Inc. 351 E. Evelyn Ave., Mountain View, CA 94041 Tel 650-934-5200 www.vivus.com (Filed With SEC on August 3, 2015)

VIVUS, Inc. 351 E. Evelyn Ave., Mountain View, CA 94041 Tel 650-934-5200 www.vivus.com (Filed With SEC on August 3, 2015)

VIVUS, Inc. 351 E. Evelyn Ave., Mountain View, CA 94041 Tel 650-934-5200 www.vivus.com (Filed With SEC on November 4, 2015)

Separation and Release of Claims Agreement between FLIR Systems, Inc. and Thomas A. Surran effective as of September 30, 2017 (Filed With SEC on October 27, 2017)

TRANSITION AGREEMENT AND RELEASE (Filed With SEC on March 14, 2013)

SEPARATION AGREEMENT AND RELEASE (Filed With SEC on February 22, 2013)

SEPARATION AGREEMENT AND RELEASE (Filed With SEC on November 8, 2013)